logo
Dr EL CO LTD
Основные продукты:Зубная паста prololis, Полоска для полосок, Накачка зубной пасты

Обзор компании

Альбом компании1

Основная информация
Dr. E.L. is committed to product research with the attitude of being responsible for family health in joint research/development with EL Dental Hospital.We would like to develop products that can be used with confidence by excluding artificial and chemical raw materials accumulated on the skin as much as possible and researching quality natural ingredients.We hope that preventive dentistry will always study and develop so that everyone can lead a healthier life. We continue to study so that the whole family can laugh and be happy.Based on experience in oral clinical trials,we have been researching and developing specialized oral care products for my teeth, such as gum disease, orthodontics, teeth whitening, and Sirin, and products consisting of natural ingredients safe for the human body. With these efforts, we are entering Europe, Singapore, and China in recognition of professional oral care products that are safe and suitable for my teeth condition.We will create new value creation for healthy oral care, consider customers as family members, and develop safe and reliable products to provide the best customer satisfaction services. We promise continuous development for the purpose of protecting the customer's safety and environment by excluding chemicals and replacing them with natural ingredients through eco-friendly management.
  • Транзакции
    -
  • Время отклика
    ≤12h
  • Частота откликов
    66.67%
Тип компании
Производитель
Страна / Регион
daejeon, South Korea
Основные продуктыВсего сотрудников
51 - 100 People
Общий годовой доход
US$2.5 Million - US$5 Million
Год основания
2016
Сертификаты
-
Сертификаты на продукцию
-
Патенты
-
Товарные знаки
-
Основные рынки

Емкость продукта

Поток производство

Информация о заводе

Размер завода
1,000-3,000 square meters
Местоположение завода
toothpaste
Число производственных линий
6
Контрактное производство
OEM Service Offered
Годовой выпуск
US$5 Million - US$10 Million

R&D возможности

Исследования и разработки

21 - 30 People